Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
John Pattullo is appointed as Marken Group Non-Executive Chairman
RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2014 /PRNewswire/ -- Marken announced today the appointment of John Pattullo as Chairman of the Board for the Marken group of companies. His appointment is effective February 1, 2014 and he will succeed Robert Ellis.
Mr. Pattullo was CEO of CEVA, a global logistics company, from 2007 until his retirement in October 2012. His previous logistics industry experience included leading the EMEA business of Exel. Before Exel, he completed a 30 year career at Procter & Gamble in various operational roles which included leading P&G supply chain activities in Asia and for their Global Beauty Care business. Mr. Pattullo's appointment was the result of an extensive industry search conducted by Marken's Board.
"We are delighted that John has agreed to join us as Chairman," said Wes Wheeler, Marken's Chief Executive Officer. "He brings a wealth of relevant industry and operating experience to our Board. I look forward to working with John as we continue our journey toward becoming the life science industry's first choice for logistics services."
"I am excited about the opportunity to serve as Marken Chairman," said Pattullo. "The company has solid fundamentals, strong growth potential and an experienced, capable executive team. I look forward to working with Wes, the executive team and the Board to sustain progress."
Pattullo is currently Chairman of the UK NHS Blood and Transplant organization, a non executive Director of Electrocomponents Plc and remains a special advisor to the Board of CEVA.
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates d and l services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.
©2012 PR Newswire. All Rights Reserved.